SCHEMBL7971820

SCHEMBL7971820

CCOC(=O)C(=N)C(=O)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.48
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPT P10636 1/20 0.45
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
MAPK1 P28482 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
AKR1B1 P15121 1/20 0.42
PAM P19021 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21185428 0.87 MEN1 (0.48) SMN1; SMN2KMT2AMEN1ALDH1A1MAPT
SCHEMBL1119176 0.86 CES2 (0.59) CES2CES1SMN1; SMN2KMT2AMEN1
SCHEMBL21769296 0.84 MAPT (0.53) CES2CES1SMN1; SMN2KMT2AMEN1
SCHEMBL23052609 0.83 MEN1 (0.50) CES2CES1SMN1; SMN2KMT2AMEN1
SCHEMBL4755209 0.83 CES2 (0.55) CES2CES1SMN1; SMN2KMT2AMEN1
SCHEMBL16578400 0.81 ALDH1A1 (0.45) SMN1; SMN2KMT2AMEN1ALDH1A1MAPT
SCHEMBL14934928 0.80 ALDH1A1 (0.61) CES2CES1SMN1; SMN2KMT2AMEN1
SCHEMBL7868721 0.79 CES2 (0.50) CES2CES1SMN1; SMN2KMT2AMEN1
SCHEMBL11317095 0.78 MEN1 (0.49) CES2CES1SMN1; SMN2KMT2AMEN1
SCHEMBL11317097 0.78 MEN1 (0.49) CES2CES1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805939-B1 Heterocyclic compounds as factor IXA inhibitors. MERCK SHARP & DOHME (US) 2018-06-27 EP disclosed
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed